Fluticasone propionate
- Generic Name
- Fluticasone propionate
- Brand Names
- Advair, Airduo, Airduo Respiclick, Aller-flo, Armonair, Beser, Cutivate, Dymista, Flonase, Flovent, Fluticare, Ticanase, Wixela, Xhance
- Drug Type
- Small Molecule
- Chemical Formula
- C25H31F3O5S
- CAS Number
- 80474-14-2
- Unique Ingredient Identifier
- O2GMZ0LF5W
- Background
Fluticasone propionate is a synthetic glucocorticoid. These drugs are available as inhalers, nasal, sprays, and topical treatments for various inflammatory indications. Fluticasone propionate was first approved in 1990.
- Indication
Fluticasone propionate is indicated as an inhaler for the treatment and management of asthma by prophylaxisas well as inflammatory and pruritic dermatoses. Fluticasone propionate nasal spray is indicated for managing allergic and nonallergic rhinitis.
- Associated Conditions
- Allergic Rhinitis (AR), Allergy to Animal Dander, Allergy to Mold, Allergy to Tree Pollen, Asthma, Bacterial Sinusitis, Chronic Bronchitis, Chronic Obstructive Pulmonary Disease (COPD), Chronic Sinusitis, Dermatitis, Emphysema, Eosinophilic Esophagitis, House Dust Mite Allergy, House dust allergy, Itching of the nose, Nasal Congestion, Non-Allergic Rhinitis, Rhinitis, Rhinitis Perennial, Rhinorrhoea, Seasonal Allergic Rhinitis, Sneezing, Moderate, severe Perennial Allergic Rhinitis (PAR), Moderate, severe Seasonal Allergic Rhinitis
- Associated Therapies
- -
Study to Analyse Difference in Bioavailability Between MP29-02 and Fluticasone Propionate
- Conditions
- Interventions
- First Posted Date
- 2016-08-30
- Last Posted Date
- 2021-07-13
- Lead Sponsor
- University Hospital, Ghent
- Registration Number
- NCT02883439
- Locations
- 🇧🇪
University Hospital Ghent, departement otorhinolaryngology, Ghent, Belgium
Ciclesonide vs Fluticasone Nasal Sprays in Nasal Poplyposis
- First Posted Date
- 2016-01-28
- Last Posted Date
- 2016-01-28
- Lead Sponsor
- Tehran University of Medical Sciences
- Target Recruit Count
- 32
- Registration Number
- NCT02665806
Effect of Extra- Fine Versus Coarse-Particle Inhaled Corticosteroids (ICS) on Ventilation Heterogeneity in Children With Poorly Controlled Asthma
- First Posted Date
- 2015-10-16
- Last Posted Date
- 2018-10-25
- Lead Sponsor
- University of Virginia
- Target Recruit Count
- 31
- Registration Number
- NCT02577497
- Locations
- 🇺🇸
University of Virginia - Fontaine Research Park, Charlottesville, Virginia, United States
Nebulized Corticosteroid for Post Extubation Stridor in Children
- First Posted Date
- 2015-08-14
- Last Posted Date
- 2017-04-27
- Lead Sponsor
- Ramathibodi Hospital
- Target Recruit Count
- 144
- Registration Number
- NCT02523820
- Locations
- 🇹🇭
Department of Pediatric,Ramathibodi Hospital, Bangkok, Thailand
A Bronchoscopy Study to Assess the Effects of Inhaled Corticosteroids on Adult Healthy Volunteers
- Conditions
- Interventions
- First Posted Date
- 2015-06-19
- Last Posted Date
- 2023-12-06
- Lead Sponsor
- University Hospitals, Leicester
- Target Recruit Count
- 30
- Registration Number
- NCT02476825
- Locations
- 🇬🇧
University Hospitals of Leicester NHS Trust, Leicester, Leics, United Kingdom
Bioequivalence Study of Synflutide HFA Inhaler and Seretide Evohaler in Healthy Volunteers Without Charcoal Block
- Conditions
- Interventions
- First Posted Date
- 2015-06-09
- Last Posted Date
- 2016-07-26
- Lead Sponsor
- Intech Biopharm Ltd.
- Target Recruit Count
- 45
- Registration Number
- NCT02466347
- Locations
- 🇨🇳
Clinical Pharmacology Unit of Mackay Memorial Hospital Tamshui Branch, New Taipei City, Taiwan
Bioequivalence Study of Synflutide HFA Inhaler and Seretide Evohaler in Healthy Volunteers With Charcoal Block
- Conditions
- Interventions
- First Posted Date
- 2015-06-09
- Last Posted Date
- 2015-06-09
- Lead Sponsor
- Intech Biopharm Ltd.
- Target Recruit Count
- 45
- Registration Number
- NCT02466503
- Locations
- 🇨🇳
Clinical Pharmacology Unit of Mackay Memorial Hospital Tamshui Branch, New Taipei City, Taiwan
A Study to Compare the Efficacy of Fluticasone Furoate/Vilanterol Inhalation Powder With Usual Inhaled Corticosteroids (ICS)/Long Acting Beta Agonists (LABA) in Persistent Asthma
- Conditions
- Interventions
- First Posted Date
- 2015-05-18
- Last Posted Date
- 2019-01-14
- Lead Sponsor
- GlaxoSmithKline
- Target Recruit Count
- 423
- Registration Number
- NCT02446418
- Locations
- 🇩🇪
GSK Investigational Site, Magdeburg, Germany
Factors Involved in Dymista's Superior Clinical Efficacy in the Treatment of Seasonal Allergic Rhinitis
- Conditions
- Interventions
- First Posted Date
- 2015-03-30
- Last Posted Date
- 2024-10-17
- Lead Sponsor
- University of Chicago
- Target Recruit Count
- 22
- Registration Number
- NCT02402465
- Locations
- 🇺🇸
The University of Chicago Medicine, Chicago, Illinois, United States
Clinical Equivalence Study of Fluticasone Propionate Nasal Spray, 50 mcg/Actuation vs. Flonase in Allergic Rhinitis Patients
- Conditions
- Interventions
- First Posted Date
- 2014-09-23
- Last Posted Date
- 2023-06-08
- Lead Sponsor
- Teva Pharmaceuticals USA
- Target Recruit Count
- 1474
- Registration Number
- NCT02246920
- Locations
- 🇺🇸
Novum Pharmaceutical Research Services, Pittsburgh, Pennsylvania, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.